Solomon Amster, MD
Family Medicine · White Lake, MINPI 1093920225
Payments from drug & device makers
Across 323 payments — averaging $3037.37 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Ortho-clinical Diagnostics, Inc.$477K
- Sanofi Pasteur Inc.$308K
- Sanofi US Services Inc.$88K
- Indivior Inc.$73K
- Merz Pharmaceuticals, LLC$36K
- USWM, LLC$130
- plus $408 from 13 others
What the payments were for
- Food & beverage$1,046100%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Ortho-clinical Diagnostics, Inc. | 5 | $476,696 |
| Sanofi Pasteur Inc. | 18 | $307,519 |
| Sanofi US Services Inc. | 13 | $87,681 |
| Indivior Inc. | 253 | $73,138 |
| Merz Pharmaceuticals, LLC | 6 | $35,500 |
| USWM, LLC | 6 | $130 |
| AstraZeneca | 6 | $101 |
| Axsome Therapeutics, Inc. | 2 | $50 |
| Lilly USA, LLC | 2 | $35 |
| Orexo US, Inc. | 2 | $35 |
| Braeburn Inc. | 2 | $27 |
| Alkermes, Inc. | 1 | $26 |
| Vanda Pharmaceuticals Inc. | 1 | $26 |
| ITI, Inc. (d/b/a Intra-cellular Therapies, Inc.) | 1 | $22 |
| E.r. Squibb & Sons, L.L.C. | 1 | $19 |
| AbbVie | 1 | $19 |
| Lundbeck LLC | 1 | $19 |
| Baxter Healthcare | 1 | $15 |
| Otsuka America Pharmaceutical, Inc. | 1 | $13 |
How this compares
$981,072 in reported general payments places this provider in the 95th percentile of 3,945 family medicine providers in Michigan.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| Buprenorphine-NaloxoneBuprenorphine Hcl/Naloxone Hcl | 25 | $2,014 |
| Atorvastatin Calcium | 18 | $198 |
| Lisinopril | 17 | $88 |
| Azithromycin | 13 | $45 |
| Prednisone | 11 | $19 |
Paid to pharmacies, not to this prescriber.
Other family medicine in White Lake
- David LeszkowitzWhite Lake$21K
- Derrick WilliamsonSouthfield$9.9M
- Rebecca RivardRoseville$7M
- Paul BensonBerkley$4.2M
- Michael HafranEast Lansing$2.7M
- Mitzie HewittBuckley$1.3M
- Loren ChudlerSouthfield$1.3M
- Matt RosenbergJackson$559K
- Rhonda MejeurGrand Rapids$493K
- Steve LasaterSaint Johns$291K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.